|
Variable
|
Gout
| |
Non-gout
|
|---|
|
Number
|
Percentage
|
Number
|
Percentage
|
|---|
|
Total number
|
41,446
| |
41,446
| |
|
Mean age (SD)
|
57.2
|
(13.6)
|
57.1
|
(13.7)
|
|
Median follow up (IQR)
|
6.0
|
(3.3, 9.5)
|
5.9
|
(3.2, 9.4)
|
|
Male
|
33,574
|
81.0
|
33,574
|
81.0
|
|
Body mass index
|
|
Normal
|
7394
|
17.8
|
12,341
|
29.8
|
|
Underweight
|
349
|
0.8
|
681
|
1.6
|
|
Overweight
|
15,537
|
37.5
|
14,760
|
35.6
|
|
Obese
|
15,311
|
36.9
|
8417
|
20.3
|
|
Missing
|
2855
|
6.9
|
5247
|
12.7
|
|
Smoking status
|
|
Never/ex-smoker
|
36,153
|
87.2
|
34,406
|
83.0
|
|
Current smoker
|
5293
|
12.8
|
7040
|
17.0
|
|
Comorbidities
|
|
Diabetes mellitus
|
2686
|
6.5
|
2417
|
5.8
|
|
Treated hypertension
|
11,982
|
28.9
|
6648
|
16.0
|
|
Rheumatoid arthritis
|
276
|
0.7
|
302
|
0.7
|
|
SLE
|
25
|
0.1
|
24
|
0.1
|
|
Heart failure
|
1342
|
3.2
|
482
|
1.2
|
|
Myocardial infarction
|
1660
|
4.0
|
1166
|
2.8
|
|
Cerebrovascular disease
|
1537
|
3.7
|
1241
|
3.0
|
|
Peripheral vascular disease
|
901
|
2.2
|
670
|
1.6
|
|
Anti-diabetic drugs
|
1847
|
4.5
|
1881
|
4.5
|
|
NSAIDs
|
5852
|
14.1
|
1619
|
3.9
|
|
Previous hospitalisations
|
11,016
|
26.6
|
9129
|
22.0
|
|
GP consultation rates (tertiles)
|
|
1
|
10,375
|
25.0
|
17,256
|
41.6
|
|
2
|
14,609
|
35.2
|
13,022
|
31.4
|
|
3
|
16,462
|
39.7
|
11,168
|
26.9
|
|
IMD quintiles
|
|
1 (least deprived)
|
10,526
|
25.4
|
10,485
|
25.3
|
|
2
|
10,220
|
24.7
|
10,232
|
24.7
|
|
3
|
8411
|
20.3
|
8330
|
20.1
|
|
4
|
7034
|
17.0
|
7164
|
17.3
|
|
5 (most deprived)
|
5216
|
12.6
|
5206
|
12.6
|
- SLE systemic lupus erythematosus, NSAID non-steroidal anti-inflammatory drug, GP general practitioner, IMD Index of multiple deprivation
